The United States Insulin Pump Market is projected to grow from US$ 1.55 billion in 2024 to US$ 2.58 billion in 2033, with a ...

ViCentra announced today that it appointed former Dexcom and Medtronic Diabetes leaders to new executive roles.

ViCentra, a European medical device company redefining insulin delivery for people with diabetes with the Kaleido insulin patch pump system, today announced two strategic senior leadership ...

Among 91 women, those who used a closed-loop insulin delivery system spent an average of 65.4% of time in pregnancy-specific ...

SAN DIEGO - Tandem Diabetes Care, Inc. (NASDAQ:TNDM), currently trading at $12 per share with annual revenues exceeding $1 billion, announced Monday that its t:slim X2 insulin pump with Control-IQ+ ...

Medtronic (NYSE:MDT) strengthens its healthcare offerings. Key sectors of Medtronic show growth. S&P 500 futures reflects trends in healthcare. Medtronic plc (NYSE:MDT) is a global leader in medical ...

Medical device maker Medtronic (MDT) said on Wednesday that it is looking to separate its Diabetes business as a standalone public company as a part of its efforts to manage its portfolio. The ...

The Global Diabetes Devices Market is projected to expand at a compound annual growth rate (CAGR) of approximately 6% by 2026. Key drivers of this growth include the rising incidence of diabetes, ...

Walmart will become the first U.S. retailer to sell Abbott’s continuous glucose monitoring device as the medtech giant looks to broaden its sales potential for its growing business unit. | Walmart ...

If you need to track your glucose daily, you probably want a pain-free option. Besides pricking your finger, there are now wearable devices that are placed on your arm and connect to an app on your ...